Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma

Jayashree Kalpathy-Cramer, Vyshak Chandra, Xiao Da, Yangming Ou, Kyrre E. Emblem, Alona Muzikansky, Xuezhu Cai, Linda Douw, John G. Evans, Jorg Dietrich, Andrew S. Chi, Patrick Y. Wen, Stephen Stufflebeam, Bruce Rosen, Dan G. Duda, Rakesh K. Jain, Tracy T. Batchelor, Elizabeth R. Gerstner